Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 101,214 | 53,163 | 37,312 | 100,362 | 57,489 |
| Gross Profit | 101,214 | 53,163 | 37,312 | 100,362 | 57,489 |
| Operating Expenses | 107,698 | 154,498 | 153,354 | 148,967 | 168,384 |
| Operating Income | -6,484 | -101,335 | -116,042 | -48,605 | -110,895 |
| Other Income | 9,807 | 2,018 | 172 | 1,809 | 8,230 |
| Pre-tax Income | 3,323 | -99,317 | -115,870 | -46,796 | -102,665 |
| Income Tax | 3,892 | N/A | N/A | -13,911 | -427 |
| Net Income Continuous | -569 | -99,317 | -115,870 | -32,885 | -102,238 |
| Net Income | $-569 | $-99,317 | $-115,870 | $-32,885 | $-102,238 |
| EPS Basic Total Ops | -0.01 | -1.51 | -1.81 | -0.71 | -2.26 |
| EPS Basic Continuous Ops | -0.01 | -1.51 | -1.81 | -0.71 | -2.26 |
| EPS Diluted Total Ops | -0.01 | -1.51 | -1.81 | -0.71 | -2.26 |
| EPS Diluted Continuous Ops | -0.01 | -1.51 | -1.81 | -0.71 | -2.26 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -1.51 | -1.30 | -0.71 | -2.26 |
| EBITDA(a) | $-11,728 | $-98,944 | $-113,064 | $-46,268 | $-110,518 |